Polyunsaturated fatty acids, melatonin, and cancer prevention

Biochemical Pharmacology

Volumn 61, Issue 12, 2001, Pages 1455-1462

  Sauer, Leonard A ^a   Dauchy, Robert T ^a   Blask, David E ^a  

^a BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

Cancer prevention; Linoleic acid; Melatonin; N3 Fatty acids; Signal transduction; Tumor growth

Indexed keywords

8 BROMO CYCLIC AMP; ANTINEOPLASTIC AGENT; CORIOLIC ACID; HORMONE RECEPTOR BLOCKING AGENT; ICOSAPENTAENOIC ACID; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LINOLEIC ACID; MELATONIN; MELATONIN RECEPTOR; MITOGENIC AGENT; N [2 (1 NAPHTHYL)ETHYL]CYCLOBUTANECARBOXAMIDE; NEUROHORMONE; NORDIHYDROGUAIARETIC ACID; POLYUNSATURATED FATTY ACID; RECEPTOR; UNCLASSIFIED DRUG;

CANCER PREVENTION; CANCER TISSUE; COMPARATIVE STUDY; DRUG MECHANISM; DRUG POTENCY; FAT INTAKE; FATTY ACID TRANSPORT; HORMONE RELEASE; HORMONE SYNTHESIS; LIVER; LIVER PERFUSION; NIGHT; NONHUMAN; PHOTOSTIMULATION; PINEAL BODY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

EID: 0035876962     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00634-7     Document Type: Article

References (61)

1. Simopoulos AP, Robinson J. The omega plan. New York: HarperCollins, 1998:41.
2. Holman R.T. The ratio of trienoic tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement . J Nutr. 70:1960;405-410.
3. Sauer L.A., Dauchy R.T., Blask D.E. Dietary linoleic acid intake controls the arterial blood plasma concentration and the rates of growth and linoleic acid uptake and metabolism in hepatoma 7288CTC in Buffalo rats. J Nutr. 127:1997;1412-1421.
4. Hillyard L.A., Abraham S. Effect of dietary polyunsaturated fatty acids on growth of mammary adenocarcinomas in mice and rats. Cancer Res. 39:1979;4430-4437.
5. Gonzalez M.J., Schemmel R.A., Gray J.I., Dugan L. Jr, Sheffield L.G., Welsch C.W. Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice relationship between carcinoma growth and lipid peroxidation product levels . Carcinogenesis. 12:1991;1231-1235.
6. Rose D.P., Hatala M.A., Connolly J.M., Rayburn J. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res. 53:1993;4686-4690.
7. Wang Y., Corr J.G., Thaler H.T., Tao Y., Fair W.R., Heston W.D.W. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst. 87:1995;1456-1462.
8. 3H-thymidine incorporation in hepatoma 7288CTC perfused in situ. Br J Cancer. 66:1992;297-303.
9. Bjerve K.S., Brekke O.-L., Fougner K.J., Midthjell K. Omega-3, and omega-6 fatty acids in serum lipids, and their relationship to human disease. Galli C., Simopoulos A.P. Dietary ω3, and ω6 fatty acids, Biological effects and nutritional essentiality. 1988;241-251 Plenum Press, New York.
10. Roebuck B.D., Longnecker D.S., Baumgartner K.J., Thron C.D. Carcinogen-induced lesions in the rat pancreas effects of varying levels of essential fatty acid . Cancer Res. 45:1985;5252-5256.
11. Ip C., Carter A.C., Ip M.M. Requirement of essential fatty acid for mammary tumorigenesis in the rat. Cancer Res. 45:1985;1997-2001.
12. Bull A.W., Bronstein J.C., Nigro N.D. The essential fatty acid requirement for azoxymethane-induced intestinal carcinogenesis in rats. Lipids. 24:1989;340-346.
13. Sauer L.A., Dauchy R.T., Blask D.E., Armstrong B.J., Scalici S. 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. Cancer Res. 59:1999;4688-4692.
14. Glasgow W.C., Hui R., Everhart A.L., Jayawickreme S.P., Angerman-Stewart J., Han B.-B., Eling T.E. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. Differential response in Syrian hamster embryo tumor suppressor phenotypes. J Biol Chem. 272:1997;19269-19276.
15. Karmali R.A., Marsh J., Fuchs C. Effect of omega-3 fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst. 73:1984;457-461.
16. Rose D.P., Connolly J.M. Effects of dietary omega-3 fatty acids on human breast cancer growth and metastasis in nude mice. J Natl Cancer Inst. 85:1993;1743-1747.
17. Welsch C.W., Welsch M.A., Huelskamp L.J., Gonzalez M.J., Vanderploeg L.C. Influence of dietary fat on growth of MDA-MB231 human breast carcinomas maintained in female athymic nude mice. Int J Oncol. 6:1995;55-64.
18. Reddy B.S., Sugie S. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 48:1988;6642-6647.
19. Cohen L.A., Chen-Backlund J.-Y., Sepkovic D.W., Sugie S. Effect of varying proportions of dietary menhaden and corn oil on experimental rat mammary tumor promotion. Lipids. 28:1993;449-453.
20. Zakim D. Fatty acids enter cells by simple diffusion. Proc Soc Exp Biol Med. 212:1996;5-14.
21. Fitscher F.A., Elsing C., Riedel H.-D., Gorski J., Stremmel W. Protein-mediated facilitated uptake processes for fatty acids, bilirubin and other amphipathic compounds. Proc Soc Exp Biol Med. 212:1996;15-23.
22. Sauer L.A., Dauchy R.T., Blask D.E. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Cancer Res. 60:2000;5289-5295.
23. Schaffer J.E., Lodish H.F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 79:1994;427-436.
24. Blask D.E., Sauer L.A., Dauchy R.T., Holowachuk E.W., Ruhoff M.S., Kopff H.S. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res. 59:1999;4693-4701.
25. Reiter R.J. Pineal melatonin cell biology of its synthesis and of its physiological interactions . Endocr Rev. 12:1991;151-180.
26. Aschoff J. Exogenous and endogenous components in circadian rhythms. Cold Spring Harb Symp Quant Biol. 25:1960;11-28.
27. Moore R.Y. Organization and function of a central nervous system circadian oscillator the suprachiasmatic nucleus . Fedn Proc. 42:1983;2783-2789.
28. Arendt J. Melatonin and the human circadian system. Miles A., Philbrick D.R.S., Thompson S. Melatonin - clinical perspectives. 1988;43-61 Oxford University Press, New York.
29. Brainard G.C., Richardson B.A., King T.S., Reiter R.J. The influence of different light spectra on the suppression of pineal melatonin content in the Syrian hamster. Brain Res. 294:1984;333-339.
30. Lynch H.J., Rivest R.W., Ronsheim P.M., Wurtman R.J. Light intensity and the control of melatonin secretion in rats. Neuroendocrinology. 33:1981;181-185.
31. Brainard G.C., Lewy A.J., Menaker M., Miller L.S., Fredrickson R.H., Weleber R.G., Cassone V., Hudson D. Dose-response relationship between light irradiance and the suppression of melatonin in human volunteers. Brain Res. 454:1988;212-218.
32. Blask D.E., Wilson S.T., Cos S., Lemus-Wilson A.M., Liaw L. Pineal and circadian influence on the inhibitory growth response of experimental breast cancer to melatonin. Proc 74th Annu Meet Endocr Soc. 1992;376.
33. Hamilton T. Influence of environmental light and melatonin upon mammary tumor induction. Br J Surg. 56:1969;764-766.
34. Blask D.E. Melatonin in oncology. Yu H.-S., Reiter R.J. Melatonin biosynthesis, physiologic effects and clinical implications. 1993;447-475 CRC Press, Boca Raton.
35. Dauchy R.T., Sauer L.A., Blask D.E., Vaughan G.M. Light contamination during the dark phase in "photoperiodically controlled" animal rooms effect on tumor growth and metabolism in rats . Lab Anim Sci. 47:1997;511-518.
36. Guardiola-Lemaitre B., Delagrange P. Melatonin agonists and antagonists pharmacological tools or therapeutic agents? Webb S.M., Puig-Domingo M., Moller M., Pevet P. Pineal update. 1997;301-319 PJD Publications, Westbury.
37. Sauer LA, Dauchy RT, Blask DE. Melatonin inhibits fatty acid transport in inguinal fat pads of hepatoma 7288CTC-bearing and normal Buffalo rats via receptor-mediated signal transduction. Life Sci, in press.
38. Tisdale M.J. Cancer cachexia. Anticancer Drugs. 4:1993;115-125.
39. Lissoni P., Paolorossi F., Tancini G., Barni S., Ardizzoia A., Brivio F., Zubelewicz B., Chatikhine V. Is there a role for melatonin in the treatment of neoplastic cachexia? Eur J Cancer. 32A:1996;1340-1343.
40. Warren S. The immediate cause of death in cancer. Am J Med Sci. 185:1932;610-615.
41. Tisdale M.J., Dhesi J.K. Inhibition of weight loss by ω-3 fatty acids in an experimental cachexia model. Cancer Res. 50:1990;5022-5026.
42. Price S.A., Tisdale M.J. Mechanism of inhibition of a tumor lipid-mobilizing factor by eicosapentaenoic acid. Cancer Res. 58:1998;4827-4831.
43. Reppert S.M., Weaver D.R. Melatonin madness. Cell. 83:1995;1059-1062.
44. Eling T.E., Glasgow W.C. Cellular proliferation and lipid metabolism importance of lipoxygenase in modulating epidermal growth factor-dependent mitogenesis . Cancer Metastasis Rev. 13:1994;397-410.
45. Reddy N., Everhart A., Eling T., Glasgow W. Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells stimulation of 13-HODE formation by TGFα/EGF . Biochem Biophys Res Commun. 231:1997;111-116.
46. Cho Y., Ziboh V.A. 13-Hydroxyoctadecadienoic acid reverses epidermal hyperproliferation via selective inhibition of protein kinase C-β activity. Biochem Biophys Res Commun. 201:1994;257-265.
47. Fischer S.M., Leyton J., Lee M.L., Locniskar M., Belury M.A., Maldve R.E., Slaga T.J., Bechtel D.H. Differential effects of dietary linoleic acid on mouse skin-tumor promotion and mammary carcinogenesis. Cancer Res. 52:(7 Suppl):1992;2049s-2054s.
48. Shureiqi I., Wojno K.J., Poore J.A., Reddy R.G., Moussalli M.J., Spindler S.A., Greenson J.K., Normolle D., Hasan A.A.K., Lawrence T.S., Brenner D.E. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis. 20:1999;1985-1995.
49. Berk P.D. How do long-chain free fatty acids cross cell membranes? Proc Soc Exp Biol Med. 212:1996;1-4.
50. Abumrad N.A., El-Maghrabi M.R., Amri E.-Z., Lopez E., Grimaldi P.J. Cloning of rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem. 268:1993;17665-17668.
51. Isola L.M., Zhou S.-L., Kiang C.-L., Stump D.D., Bradbury M.W., Berk P.D. 3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma membrane fatty acid-binding protein, and saturable fatty acid uptake. Proc Natl Acad Sci USA. 92:1995;9866-9870.
52. Hirsch D., Stahl A., Lodish H.F. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA. 95:1998;8625-8629.
53. Hui T.Y., Frohnert B.I., Smith A.J., Schaffer J.E., Bernlohr D.A. Characterization of the murine fatty acid transport protein gene and its insulin response sequence. J Biol Chem. 273:1998;27420-27429.
54. Bonen A., Luiken J.J.F.P., Arumugam Y., Glatz J.F.C., Tandon N.N. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem. 275:2000;14501-14508.
55. Tamarkin L., Cohen M., Roselle D., Reichter C., Lippman M., Chabner B. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(α)anthracence-induced mammary tumors in the rat. Cancer Res. 41:1981;4432-4436.
56. Molis T., Spriggs L.L., Jupiter Y., Hill S.M. Melatonin modulation of estrogen-regulated proteins, growth factors and protooncogenes in human breast cancer. J Pineal Res. 18:1995;93-103.
57. Lemus-Wilson A., Kelly P.A., Blask D.E. Melatonin blocks the stimulatory effects of prolactin on human breast cancer growth in culture. Br J Cancer. 72:1995;1435-1440.
58. 2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res. 56:1996;532-537.
59. Singh J., Hamid R., Reddy B.S. Dietary fat and colon cancer modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer . Cancer Res. 57:1997;253-258.
60. Palakurthi S.S., Flückiger R., Aktas H., Changolkar A.K., Shahsafaei A., Harneit S., Kilic E., Halperin J.A. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res. 60:2000;2919-2925.
61. Albino A.P., Juan G., Traganos F., Reinhart L., Connolly J., Rose D.P., Darzynkiewicz Z. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid association with decreased pRb phosphorylation . Cancer Res. 60:2000;4139-4145.